TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 44 filers reported holding TOKAI PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $343,000 | -2.3% | 411,100 | +14.4% | 0.00% | -100.0% |
| Q4 2016 | $351,000 | +6.4% | 359,200 | +66.3% | 0.00% | 0.0% |
| Q3 2016 | $330,000 | +334.2% | 216,000 | +1465.2% | 0.00% | – |
| Q2 2016 | $76,000 | -20.8% | 13,800 | -19.8% | 0.00% | – |
| Q1 2016 | $96,000 | -73.9% | 17,200 | -59.2% | 0.00% | -100.0% |
| Q4 2015 | $368,000 | – | 42,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 321,600 | $492,000 | 0.02% |
| NJ State Employees Deferred Compensation Plan | 35,000 | $54,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 452,800 | $693,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 12,000 | $18,000 | 0.01% |
| Spark Investment Management LLC | 35,400 | $54,000 | 0.00% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $9,000 | 0.00% |
| Acrospire Investment Management LLC | 3,446 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 15,866 | $24,000 | 0.00% |
| Renaissance Technologies | 216,000 | $330,000 | 0.00% |
| IFP Advisors, Inc | 2,750 | $4,000 | 0.00% |